Fortescue shares: Buy, hold, or fold?

Could the future look brighter?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The Fortescue share price has underperformed the market so far this year, falling 16% year to date to trade at $16.76 
  • And many brokers aren't expecting a recovery anytime soon, with one tipping a potential 28% downside on the stock's current level 
  • Some experts are worried about the company's dividends in the face of its commitment to decarbonisation 

It's been a rough year so far for shares in S&P/ASX 200 Index (ASX: XJO) iron ore (and green energy) favourite, Fortescue Metals Group Limited (ASX: FMG).

The stock has slumped around 16% year to date while the iconic index has dumped 13%.

The Fortescue share price last traded at $16.76. So, could it be about to embark on the path to recovery?

Most brokers think not. Let's take a look at what experts are predicting for the future of the Fortescue share price.

A group of three men in hard hats and high visibility vests stand together at a mine site while one points and the others look on with piles of dirt and mining equipment in the background.

Image source: Getty Images

What might the future hold for Fortescue shares?

Fortescue shares – like those of its fellow ASX 200 materials giants – are often heralded as a dividend haven. Indeed, the company is currently trading with a 12.36% yield, having offered investors $2.07 of dividends per share over the last 12 months.

On top of that, the company has likely garnered interest on the back of its green energy leg, Fortescue Future Industries.

But its apparent commitment to decarbonisation and the energy transition may dint its dividends, according to experts.

Goldman Sachs expects the company's recently announced plan to decarbonise its Pilbara operations at a cost of US$6.2 billion to likely see its payout ratio drop from 75% to 50% from financial year 2024. Though, the company believes the move will deliver US$3 billion of cost savings by 2030 and payback of capital by 2034.

The broker has a sell rating and a $12.10 price target on Fortescue shares. That represents a potential 28% downside.

Macquarie and Morgan Stanley share similar concerns about the company's dividends, The Australian reports.

They're said to have respectively slapped the stock with underperform and underweight ratings and price targets of $14.30 and $15.15.

Meanwhile, UBS analysts are reportedly worried about iron ore prices, leading the broker to tip Fortescue as a sell and hit its shares with a $15.80 price target.

But not all experts are so bearish on the future of the Fortescue share price.

Morgans apparently believes the stock is trading at a decent price right now. It has a hold rating and a $17.30 price target on the company's shares, as my Fool colleague James reports.

Though, the broker also offers a potentially disappointing outlook for Fortescue's dividends. It's expecting the company's full-year payout to slip to 37 US cents by financial year 2026.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs. The Motley Fool Australia has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Buy, hold, sell: Northern Star, Telix, and Virgin Australia shares

Let’s see if they are bullish or bearish on these names.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Forget CBA shares and buy this ASX ETF: experts

Here's what experts are saying about these two investment options.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: BHP, Guzman Y Gomez, and Pro Medicus shares

Are brokers bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Humanoid robot analysing the stock market, symbolising artificial intelligence shares.
Broker Notes

Up 109% since November, are Appen shares still a buy today?

A leading expert digs into the outlook for Appen shares amid the rise of AI.

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »

Miner and company person analysing results of a mining company.
Broker Notes

3 reasons to buy BHP shares today

Two leading investment analysts offer their outlook for the BHP share price.

Read more »

Three happy team mates holding the winners trophy.
Broker Notes

What's Bell Potter's updated view on Catapult shares after its earnings results?

This ASX tech stock could be set for growth.

Read more »